| 标题 |
Combination therapy with HT-101 and HT-102 achieved rapid and progressive HBsAg loss in HBeAg-negative, nucleos(t)ide analogues-suppressed patients: 12-week interim results from an ongoing multicentre, open-label phase Ib/IIa study
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)